1Lepage, C, Rachet, B, Jooste, V, et al. (2008) Continuing rapid increase in esophageal adenocarcinoma in England and Wales. Am J Gastroenterol 103, 2694–2699.
2El-Serag, HB (2007) Time trends of gastroesophageal reflux disease: a systematic review. Clin Gastroenterol Hepatol 5, 17–26.
3Shaheen, NJ & Richter, JE (2009) Barrett's oesophagus. Lancet 373, 850–861.
4Wood, RK & Yang, YX (2008) Barrett's esophagus in 2008: an update. Keio J Med 57, 132–138.
5Yousef, F, Cardwell, C, Cantwell, MM, et al. (2008) The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: a systematic review and meta-analysis. Am J Epidemiol 168, 237–249.
6Thomas, T, Abrams, KR, De Caestecker, JS, et al. (2007) Meta analysis: cancer risk in Barrett's oesophagus. Aliment Pharmacol Ther 26, 1465–1477.
7Terry, P, Lagergren, J, Wolk, A, et al. (2000) Reflux-inducing dietary factors and risk of adenocarcinoma of the esophagus and gastric cardia. Nutr Cancer 38, 186–191.
8El-Serag, HB, Satia, JA & Rabeneck, L (2005) Dietary intake and the risk of gastro-oesophageal reflux disease: a cross sectional study in volunteers. Gut 54, 11–17.
9Anderson, LA, Watson, RG, Murphy, SJ, et al. (2007) Risk factors for Barrett's oesophagus and oesophageal adenocarcinoma: results from the FINBAR study. World J Gastroenterol 13, 1585–1594.
10Kubo, A, Levin, TR, Block, G, et al. (2008) Dietary antioxidants, fruits, and vegetables and the risk of Barrett's esophagus. Am J Gastroenterol 103, 1614–1623, .
11Thompson, OM, Beresford, SA, Kirk, EA, et al. (2009) Vegetable and fruit intakes and risk of Barrett's esophagus in men and women. Am J Clin Nutr 89, 890–896.
12World Cancer Research Fund/American Institute for Cancer Research (2007) Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington DC: AICR.
13Mulholland, HG, Cantwell, MM, Anderson, LA, et al. (2009) Glycemic index, carbohydrate and fiber intakes and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma. Cancer Causes Control 20, 279–288.
14Giovannucci, E (2008) Vitamin D and cancer incidence in the Harvard cohorts. Ann Epidemiol 19, 84–88.
15Dusso, AS, Brown, AJ & Slatopolsky, E (2005) Vitamin D. Am J Physiol Renal Physiol 289, F8–28.
16Gorham, ED, Garland, CF, Garland, FC, et al. (2007) Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis. Am J Prev Med 32, 210–216.
17Wei, MY, Garland, CF, Gorham, ED, et al. (2008) Vitamin D and prevention of colorectal adenoma: a meta-analysis. Cancer Epidemiol Biomarkers Prev 17, 2958–2969.
18Stolzenberg-Solomon, RZ, Vieth, R, Azad, A, et al. (2006) A prospective nested case–control study of vitamin D status and pancreatic cancer risk in male smokers. Cancer Res 66, 10213–10219.
19Abnet, CC, Chen, W, Dawsey, SM, et al. (2007) Serum 25(OH)-vitamin D concentration and risk of esophageal squamous dysplasia. Cancer Epidemiol Biomarkers Prev 16, 1889–1893.
20Chen, W, Dawsey, SM, Qiao, YL, et al. (2007) Prospective study of serum 25(OH)-vitamin D concentration and risk of oesophageal and gastric cancers. Br J Cancer 97, 123–128.
21Davis, CD (2008) Vitamin D and cancer: current dilemmas and future research needs. Am J Clin Nutr 88, 565S–569S.
22Anderson, LA, Johnston, BT, Watson, RG, et al. (2006) Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence. Cancer Res 66, 4975–4982.
23Nayar, DS & Vaezi, MF (2004) Classifications of esophagitis: who needs them? Gastrointest Endosc 60, 253–257.
24Day, N, Oakes, S, Luben, R, et al. (1999) EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. Br J Cancer 80, Suppl. 1, 95–103.
25Harrington, KE, Robson, PJ, Kiely, M, et al. (2001) The North/South Ireland Food Consumption Survey: survey design and methodology. Public Health Nutr 4, 1037–1042.
26Anderson, LA, Murphy, SJ, Johnston, BT, et al. (2008) Relationship between Helicobacter pylori infection and gastric atrophy and the stages of the oesophageal inflammation, metaplasia, adenocarcinoma sequence: results from the FINBAR case–control study. Gut 57, 734–739.
27Mayne, ST, Risch, HA, Dubrow, R, et al. (2001) Nutrient intake and risk of subtypes of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev 10, 1055–1062.
28Navarro Silvera, SA, Mayne, ST, Risch, H, et al. (2008) Food group intake and risk of subtypes of esophageal and gastric cancer. Int J Cancer 123, 852–860.
29Garland, CF, Garland, FC, Gorham, ED, et al. (2006) The role of vitamin D in cancer prevention. Am J Public Health 96, 252–261.
30Koohdani, F, Baghdadchi, J, Sasani, F, et al. (2008) Effects of vitamin D in lung, stomach, esophagus and testis tissues following administration of urethane in balb/c mice. Saudi Med J 29, 340–344.
31Kull, M, Kallikorm, R & Lember, M (2009) Body mass index determines sunbathing habits: implications on vitamin D levels. Intern Med J 39, 256–258.
32Konradsen, S, Ag, H, Lindberg, F, et al. (2008) Serum 1,25-dihydroxy vitamin D is inversely associated with body mass index. Eur J Nutr 47, 87–91.
33Lagunova, Z, Porojnicu, AC, Lindberg, F, et al. (2009) The dependency of vitamin D status on body mass index, gender, age and season. Anticancer Res 29, 3713–3720.
34Nasri, H & Baradaran, A (2007) The influence of serum 25-hydroxy vitamin D levels on Helicobacter pylori infections in patients with end-stage renal failure on regular hemodialysis. Saudi J Kidney Dis Transpl 18, 215–219.
35Abnet, CC, Chen, Y, Chow, WH, et al. (2010) Circulating 25-hydroxyvitamin D and risk of esophageal and gastric cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol 172, 94–106.
36Nishida, S, Ozeki, J & Makishima, M (2009) Modulation of bile acid metabolism by 1alpha-hydroxyvitamin D3 administration in mice. Drug Metab Dispos 37, 2037–2044.
37Bernstein, H, Bernstein, C, Payne, CM, et al. (2005) Bile acids as carcinogens in human gastrointestinal cancers. Mutat Res 589, 47–65.
38Helzlsouer, KJ & VDPP Steering Committee (2010) Overview of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol 172, 4–9.
39Stolzenberg-Solomon, RZ, Jacobs, EJ, Arslan, AA, et al. (2010) Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol 172, 81–93.
40Millen, AE, Wactawski-Wende, J, Pettinger, M, et al. (2010) Predictors of serum 25-hydroxyvitamin D concentrations among postmenopausal women: the Women's Health Initiative Calcium plus Vitamin D clinical trial. Am J Clin Nutr 91, 1324–1335.
41O'Brien, MM, Kiely, M, Harrington, KE, et al. (2001) The North/South Ireland Food Consumption Survey: vitamin intakes in 18–64-year-old adults. Public Health Nutr 4, 1069–1079.
42Hannon, EM, Kiely, M, Harrington, KE, et al. (2001) The North/South Ireland Food Consumption Survey: mineral intakes in 18–64-year-old adults. Public Health Nutr 4, 1081–1088.
43O'Sullivan, M, Nic Suibhne, T, Cox, G, et al. (2008) High prevalence of vitamin D insufficiency in healthy Irish adults. Ir J Med Sci 177, 131–134.
44Fitzgerald, RC (2004) Review Article: Barrett's oesophagus and associated adenocarcinoma – a UK perspective. Aliment Pharmacol Ther 20, Suppl. 8, 45–49.